Results 171 to 180 of about 55,587 (208)

Understanding Biologics in CRSwNP: Related Events and Insights. [PDF]

Curr Allergy Asthma Rep
Izquierdo-Domínguez A, Al-Salloom Z, Viñas M, Mullol J, Alobid I.   +4 more
europepmc   +1 more source

Generalized Bullous Fixed Drug Eruption due to Clopidogrel Hypersensitivity Successfully Treated Using the Jefferson Procedure. [PDF]

J Cutan Pathol
Gillespie J, Jiang AJ, Fett N, Shea M, Keller JJ, Daryani S.   +5 more
europepmc   +1 more source

The evolving spectrum of type 2 inflammation and beyond. [PDF]

Allergy Asthma Proc
europepmc   +1 more source

Successful management of IgE-mediated protamine allergy in cardiac surgery: bicentric case report. [PDF]

BMC Anesthesiol
Portran P, Charvin M, Jacquet-Lagreze M, Didier L, Pozzi M, Sebbag L, Bensaid B, Fellahi JL.   +7 more
europepmc   +1 more source

Effect of preexisting human leukocyte antigen donor-specific antibodies especially human leukocyte antigen-DQ on kidney transplant outcome. [PDF]

Front Nephrol
Mehrotra S, Sharma RK, Kapoor R, Jaiswal RK, Kapoor R.   +4 more
europepmc   +1 more source

Safety and efficacy of rituximab-free ABO incompatible kidney transplantation: a German multicenter cohort study. [PDF]

Front Nephrol
Pein U, Budde K, Liefeldt L, Gäckler A, Weimer R, Karakizlis H, Sommerer C, Benning L, Kurschat C, Stippel D, Harth A, Weinmann-Menke J, Koch M, Kortus-Goetze B, Reuter S, Lachmann N, Mühlfeld A.   +16 more
europepmc   +1 more source

Development and pilot validation of a chemiluminescence immunoassay for monitoring immunologic changes during peanut oral immunotherapy using sIgE/sIgG4 ratio. [PDF]

Front Allergy
Yang X, Vanderkallen A, Yu JJ, Chen J, Wan L, Li HH, Li Z, Zhu Y, Xi I.   +8 more
europepmc   +1 more source

Tolerance induction for EGFR TKI hypersensitivity in lung cancer: Case report and review. [PDF]

J Allergy Clin Immunol Glob
Haraguchi Hashiguchi M, Adachi T, Asaoka M, Ito T, Kaburagi S, Kagyo J, Okata-Karigane U, Takahashi C, Tahara U, Yoneda S, Masaki K, Fukunaga K.   +11 more
europepmc   +1 more source

Combined omalizumab and desensitization to control IgE-mediated hypersensitivity in enzyme replacement therapy for late-onset Pompe disease. [PDF]

Orphanet J Rare Dis
Lerario A, Abati E, Sciacco M, Comi GP, Desantis V, D'Amore S, Solimando AG, Ria R, Corti S, Spataro F.   +9 more
europepmc   +1 more source

Impact and outcomes after desensitization therapy in highly sensitized heart transplant candidates. [PDF]

Am J Transplant
Jain R, Nikolova A, Kittleson M, Kransdorf EP, Chang D, Deckerman P, Kobashigawa JA.   +6 more
europepmc   +1 more source